Skip to main content

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Projects

Incorporació Dr. Daniel Serón a la RETICS en Malalties renals

IP: Daniel Serón Micas
Collaborators: Gema Ariceta Iraola, Joan López Hellin, Anna Meseguer Navarro, Ramón Vilalta Casas, Francesc Moreso Mateos, Enric Trilla Herrera, Natalia Ramos Terrades, David Lorente García, Maria Jose Soler Romeo, Meritxell Ibernon Vilaró, Joana Sellarés Roig, María Eugenia Espinel Garuz, Luis Enrique Lara Moctezuma, Irene Agraz Pamplona, Marina Muñoz López, Irina Betsabe Torres Rodriguez, Luis Augusto Castro Sáder, Manel Perelló Carrascosa
Funding agency: Instituto de Salud Carlos III
Funding: 102300
Reference: RD16/0009/0030
Duration: 01/01/2017 - 31/12/2021

Could TIM-1 constitute a new target for renal carcinoma immunotherapy?

IP: Anna Meseguer Navarro
Collaborators: Enric Trilla Herrera
Funding agency: American Association for Cancer Research
Funding: 224498.8
Reference: KURE-IT_AACR2016
Duration: 01/07/2016 - 31/12/2018

Dianas dependientes de andrógenos involucradas en procesos de daño y regeneración renal capaces de promover la progresión hacia la enfermedad renal crónica y el desarrollo de enfermedad cronica de riñon y cáncer.

IP: Anna Meseguer Navarro
Collaborators: Enric Trilla Herrera, David Lorente García
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 229900
Reference: SAF2014-59945-R
Duration: 01/01/2015 - 31/12/2017

Kidney Integration sofware: Developing a new tool for diagnostic and decision making treatments for Kidney Tumours (KINESICS)

IP: Anna Meseguer Navarro
Collaborators: -
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 23000
Reference: EUIN2013-51201
Duration: 01/12/2014 - 30/11/2017

Related news

The communication is part of a study aimed at identifying the mechanisms of progression of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis, a rare disease that affects the kidneys.

"Patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis present miRNA profiles in urinary extracellular vesicles associated with disease progression" was the awarded work.

Researchers at the VHIR have carried out a study showing that the ClC-5 protein regulates collagen levels through the β-catenin pathway and lysosomal degradation.

Related professionals

Sebastian Lazaro

Sebastian Lazaro

Research technician
Genetics Medicine
Read more
Anna Llort Sales

Anna Llort Sales

Childhood Cancer and Blood Disorders
Read more
Marc Simo Perdigo

Marc Simo Perdigo

Molecular Medical Imaging
Read more
Joaquim Sola  Santesmases

Joaquim Sola Santesmases

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.